Single-Dose Psilocybin for Treatment-Resistant Major Depression

Is psilocybin a viable treatment for MDD? Researchers performed a phase 2, double blind trial of single-dose psilocybin in patients with treatment resistant depression.

Related Keywords

United States ,Georgia ,American ,America , ,Health Behavior At Augusta University ,Department Of Psychiatry ,Augusta University ,National Institute Of Mental Health ,Stanley Medical Research Institute ,African American ,Rating Scale ,North America ,Columbia Suicide Severity Rating Scale ,Health Behavior ,Editorial Board ,Psychiatric Times ,National Institute ,Mental Health ,Stanley Medical Research ,